Mankind Pharma Ltd

Mankind Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mankind Pharma Ltd

₹ 2,249 -0.42%
27 Nov - close price
mankindpharma.com BSE: 543904 NSE: MANKIND
About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Key Points

Leadership[1]
- 1 Rank in Prescriptions over the last 5 yrs.
- Youngest in the Top 5 of the IPM
- 4 By value in the IPM
- 4 Consumer Healthcare brands Market ranked
1 in their categories

Website BSE NSE
  • Market Cap ₹ 92,848 Cr.
  • Current Price ₹ 2,249
  • High / Low ₹ 3,055 / 2,115
  • Stock P/E 55.7
  • Book Value ₹ 376
  • Dividend Yield 0.04 %
  • ROCE 15.0 %
  • ROE 13.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
2,258 1,936 1,872 2,092 2,260 2,209 2,007 2,413 2,544 2,414 2,127 2,541 2,609
1,735 1,563 1,491 1,594 1,662 1,636 1,482 1,837 1,781 1,668 1,650 1,868 1,916
Operating Profit 522 374 381 498 598 573 526 576 763 746 477 673 693
OPM % 23% 19% 20% 24% 26% 26% 26% 24% 30% 31% 22% 26% 27%
69 32 42 87 84 92 109 125 139 70 219 64 78
Interest 8 9 1 2 4 4 4 7 3 200 162 147 147
Depreciation 66 71 67 69 77 90 87 91 90 91 105 97 99
Profit before tax 517 326 355 514 601 571 543 603 810 525 429 494 525
Tax % 19% 24% 21% 20% 21% 15% 14% 16% 20% 22% 11% 16% 13%
420 249 281 409 473 487 468 506 645 412 382 413 459
EPS in Rs 10.49 6.21 7.01 10.22 11.80 12.16 11.68 12.62 16.11 9.99 9.27 10.00 11.12
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
3,918 3,829 4,794 5,530 7,486 8,127 8,629 9,498 9,691
3,141 3,124 3,550 4,151 5,644 6,429 6,358 6,930 7,102
Operating Profit 778 705 1,244 1,379 1,842 1,698 2,272 2,567 2,589
OPM % 20% 18% 26% 25% 25% 21% 26% 27% 27%
209 64 94 148 200 163 369 550 432
Interest 18 40 11 8 48 28 17 372 656
Depreciation 28 38 62 78 123 270 335 378 392
Profit before tax 941 691 1,265 1,440 1,871 1,563 2,289 2,367 1,972
Tax % 26% 26% 24% 25% 26% 20% 18% 18%
694 514 958 1,084 1,389 1,248 1,876 1,945 1,666
EPS in Rs 17.33 12.83 23.92 27.07 34.68 31.16 46.84 47.15 40.38
Dividend Payout % 0% 0% 32% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 8%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: 12%
3 Years: 8%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -12%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 17%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 40 40 40 40 40 40 40 41 41
Reserves 2,957 3,025 3,611 4,694 6,500 7,744 9,663 14,599 15,469
360 190 3 101 688 5 24 7,254 7,248
652 596 877 1,045 1,710 1,583 1,790 1,934 2,104
Total Liabilities 4,009 3,851 4,531 5,880 8,939 9,371 11,516 23,828 24,862
534 778 945 987 2,927 3,142 3,552 3,471 3,393
CWIP 322 211 148 166 387 495 209 207 248
Investments 1,402 1,698 1,784 2,397 2,526 3,102 4,215 16,683 17,611
1,751 1,164 1,655 2,330 3,100 2,632 3,540 3,467 3,610
Total Assets 4,009 3,851 4,531 5,880 8,939 9,371 11,516 23,828 24,862

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
540 537 960 1,022 821 1,799 1,983 2,322
-516 -306 -396 -1,127 -1,360 -1,041 -1,919 -12,179
8 -240 -559 89 579 -710 -9 9,845
Net Cash Flow 31 -9 5 -16 40 48 55 -11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 23 13 32 24 23 22 33 34
Inventory Days 120 126 124 169 183 132 160 153
Days Payable 115 101 113 122 133 103 75 79
Cash Conversion Cycle 27 38 43 72 73 52 118 108
Working Capital Days 95 44 41 42 26 40 55 -48
ROCE % 22% 36% 33% 30% 21% 24% 15%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
76.50% 76.50% 76.50% 74.88% 74.87% 74.87% 72.71% 72.70% 72.67% 72.67%
4.18% 4.18% 6.74% 9.87% 11.58% 12.37% 13.34% 12.92% 13.07% 12.83%
4.65% 4.56% 9.78% 11.14% 9.94% 9.91% 11.05% 11.47% 11.50% 11.91%
14.67% 14.76% 6.97% 4.10% 3.61% 2.86% 2.89% 2.89% 2.75% 2.57%
No. of Shareholders 1,31,9181,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,5971,79,5491,70,347

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls